Details
Alpha 1 Antitrypsin Deficiency (AATD) Financial Cost
|
3,99 € |
|
| Verlag: | Azhar Sario Authorship and Publishing |
| Format: | EPUB |
| Veröffentl.: | 08.09.2024 |
| ISBN/EAN: | 9783759250186 |
| Sprache: | englisch |
| Anzahl Seiten: | 51 |
Dieses eBook enthält ein Wasserzeichen.
Beschreibungen
“Alpha-1 Antitrypsin Deficiency (AATD) Financial Cost” provides an in-depth analysis of the financial burdens associated with Alpha-1 Antitrypsin Deficiency (AATD), referencing 14 unique research studies. These studies cover various aspects of medical expenses, including augmentation therapy, hospitalization, emergency care, outpatient care, and the long-term financial impact on patients and families. The book offers valuable insights into the economic challenges faced by AATD patients and their families, helping them make informed decisions about treatment options, insurance coverage, and resource allocation. The book contributes to the development of healthcare strategies by highlighting the cost-effectiveness of various treatment options and identifying areas where financial support is needed. It brings innovative ideas and research by examining emerging treatments, such as gene therapy and small molecule therapies, and their economic impact. Additionally, the book offers strategies for reducing healthcare costs and improving the overall quality of life for AATD patients. This comprehensive approach makes it a valuable resource for anyone interested in the financial aspects of healthcare and the management of Alpha-1 Antitrypsin Deficiency.
Explore the financial burdens of Alpha-1 Antitrypsin Deficiency, offering insights into treatment costs, economic impact, and innovative healthcare strategies.
I am bestselling author. I have proven technical skills (Google certifications) to deliver insightful books with ten years of business experience.
Diese Produkte könnten Sie auch interessieren:
The Neural Crest and Neural Crest Cells in Vertebrate Development and Evolution
von: Brian K. Hall
149,79 €
